Similar articles

• Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.

  Teljeur C, Flattery M, Harrington P, O'Neill M, Moran PS, Murphy L, Ryan M. Teljeur C, et al. Transfusion. 2012 Nov;52(11):2285-93. doi: 10.1111/j.1537-2995.2012.03637.x. Epub 2012 Apr 9. Transfusion. 2012. PMID: 22486387
• Variant Creutzfeldt-Jakob disease and prions in the blood supply.

  Rohwer RG, Drohan W. Rohwer RG, et al. Clin Adv Hematol Oncol. 2004 Feb;2(2):84, 87, 131. Clin Adv Hematol Oncol. 2004. PMID: 16163166 No abstract available.
• Blood-transmitted prions and variant Creutzfeldt-Jakob disease.

  Grady GF, Vyas GN. Grady GF, et al. Biologicals. 2007 Apr;35(2):75-7. doi: 10.1016/j.biologicals.2007.01.005. Epub 2007 Feb 20. Biologicals. 2007. PMID: 17317213 No abstract available.
• Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented?

  Vamvakas EC. Vamvakas EC. Transfus Med Rev. 2011 Apr;25(2):133-44. doi: 10.1016/j.tmrv.2010.11.005. Epub 2011 Feb 23. Transfus Med Rev. 2011. PMID: 21345641 Review.
• ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].

  van Aken WG. van Aken WG. Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1444-7. Ned Tijdschr Geneeskd. 2001. PMID: 11503311 Review. Dutch.